Trade & Finance Updates
Discussions regarding the India-US trade pact are underway. Several companies showcased strong financial performance. Eris Lifesciences saw a 40% increase
in PAT, while Prestige Estates reported a 26% rise in Q1 profit, and Lupin’s Q1 profit jumped 52% to Rs 1,221 Cr. Furthermore, Britannia's Q1 profit rose by 3% to Rs 520 Cr. Meanwhile, banks' profitability is expected to moderate in FY26.
Infrastructure & Investment
DLF targets Rs 20K-22K crore in pre-sales this fiscal year. Mahindra has launched new CEV-V construction equipment. IndiGo has begun construction of an MRO facility in Bengaluru. DP World is launching rail freight routes connecting Gujarat to Kolkata. Ashiana Housing will invest Rs 425 Cr in senior living projects. Several funding rounds have been completed, including Rs 225 Cr for Fibe and Rs 250 Cr for Ummeed Housing.
Tech & Innovation Moves
Force Motors launched an AI fleet analytics platform, while SAP and Gati Shakti are partnering for logistics skilling. TurboHire has raised $6M for global expansion, and Kaspersky is expanding to Tier 2 cities in India. A significant discovery was made with the finding of a Nickel-Copper-PGE deposit in Chhattisgarh. AI investments were also in focus with Khetika Plant launch.
Policy & Regulatory
The Finance Ministry confirmed that Rs 500 notes will remain in circulation. RBI has tweaked procedures for Rupee Vostro account opening. SEBI has outlined guidelines for MII penalty waivers. DGCA suspended an Akasa Air pilot approval. The CCI has approved Dalmia Bharat's deal with Jaiprakash Associates and the INSCO takeover of HNG. The J&K Drug Regulator has canceled licenses.
Industry Highlights
Theobroma will be acquired by ChrysCapital. Butterfly Gandhimathi's Q1 profit rose. The government increased funding for stray dog sterilisation. FHRAI and ETS are working on English benchmarks for hospitality. The CCI has approved Dalmia Bharat's deal with Jaiprakash Associates.Wheels India is expanding to Europe. Alembic Pharma's Q1 profit is up by 14% to Rs 154 Cr. Indian firms are also discussing market access in China.
